// App-Quantinova.ai

: Efficiency and Safety of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Patients with Double Expressor Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Study

Researchers

Presenter

  • Meichen Liu

Principal Investigators

  • Qianxue Guo

  • Bin Liu

  • Xinning Xu

  • Mengdan Xu

  • Lili Liu

  • Xinxin Li

  • Xiaojing Xing

Medical Centers

  • Liaoning Cancer Hospital & Institute, Shenyang, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Vincristine

  • Doxorubicin

  • Prednisone

  • Rituximab

Outcome

  • N/A

Study Design

  • Safety

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved